OLMA
Olema Pharmaceuticals, Inc.
Key Financials
Net Income
$-162451000
↓ 25.5%
EPS (Diluted)
$-1.87
↑ 15.0%
Total Assets
$533.4M
↑ 18.3%
Operating Income
$-178698000
↓ 25.6%
Total Liabilities
$54.9M
↑ 30.6%
Shareholders' Equity
$478.6M
↑ 17.0%
Cash & Equivalents
$48.3M
↓ 65.4%
Operating Cash Flow
$-146716000.00
↓ 40.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| 10-Q | 5/12/2026 | View on SEC |
| 8-K | 5/12/2026 | View on SEC |
| 8-K | 5/1/2026 | View on SEC |
| 4 | 4/29/2026 | View on SEC |
| 3 | 4/29/2026 | View on SEC |
| ARS | 4/29/2026 | View on SEC |
| DEFA14A | 4/29/2026 | View on SEC |
| DEF 14A | 4/29/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | OLMA |
| Company Name | Olema Pharmaceuticals, Inc. |
| CIK | 1750284 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (415) 651-3316 |